188 related articles for article (PubMed ID: 19567823)
1. Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors.
Yuan X; Lin X; Manorek G; Kanatani I; Cheung LH; Rosenblum MG; Howell SB
Mol Cancer Ther; 2009 Jul; 8(7):1906-15. PubMed ID: 19567823
[TBL] [Abstract][Full Text] [Related]
2. Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer.
Cocco E; Casagrande F; Bellone S; Richter CE; Bellone M; Todeschini P; Holmberg JC; Fu HH; Montagna MK; Mor G; Schwartz PE; Arin-Silasi D; Azoudi M; Rutherford TJ; Abu-Khalaf M; Pecorelli S; Santin AD
BMC Cancer; 2010 Jul; 10():349. PubMed ID: 20598131
[TBL] [Abstract][Full Text] [Related]
3. C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin.
Gao Z; Xu X; McClane B; Zeng Q; Litkouhi B; Welch WR; Berkowitz RS; Mok SC; Garner EI
Clin Cancer Res; 2011 Mar; 17(5):1065-74. PubMed ID: 21123456
[TBL] [Abstract][Full Text] [Related]
4. Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency.
Yuan X; Lin X; Manorek G; Howell SB
BMC Cancer; 2011 Feb; 11():61. PubMed ID: 21303546
[TBL] [Abstract][Full Text] [Related]
5. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
Shang X; Lin X; Alvarez E; Manorek G; Howell SB
Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
[TBL] [Abstract][Full Text] [Related]
7. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
8. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
[TBL] [Abstract][Full Text] [Related]
9. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.
Litkouhi B; Kwong J; Lo CM; Smedley JG; McClane BA; Aponte M; Gao Z; Sarno JL; Hinners J; Welch WR; Berkowitz RS; Mok SC; Garner EI
Neoplasia; 2007 Apr; 9(4):304-14. PubMed ID: 17460774
[TBL] [Abstract][Full Text] [Related]
10. Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
Pahle J; Menzel L; Niesler N; Kobelt D; Aumann J; Rivera M; Walther W
BMC Cancer; 2017 Feb; 17(1):129. PubMed ID: 28193196
[TBL] [Abstract][Full Text] [Related]
11. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin.
Ebihara C; Kondoh M; Hasuike N; Harada M; Mizuguchi H; Horiguchi Y; Fujii M; Watanabe Y
J Pharmacol Exp Ther; 2006 Jan; 316(1):255-60. PubMed ID: 16183701
[TBL] [Abstract][Full Text] [Related]
12. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
[TBL] [Abstract][Full Text] [Related]
13. A claudin 3 and claudin 4-targeted Clostridium perfringens protoxin is selectively cytotoxic to PSA-producing prostate cancer cells.
Romanov V; Whyard TC; Waltzer WC; Gabig TG
Cancer Lett; 2014 Sep; 351(2):260-4. PubMed ID: 24952257
[TBL] [Abstract][Full Text] [Related]
14. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.
Rangel LB; Agarwal R; D'Souza T; Pizer ES; Alò PL; Lancaster WD; Gregoire L; Schwartz DR; Cho KR; Morin PJ
Clin Cancer Res; 2003 Jul; 9(7):2567-75. PubMed ID: 12855632
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.
Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK
Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191
[TBL] [Abstract][Full Text] [Related]
18. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
Uthayanan L; El-Bahrawy M
J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
[TBL] [Abstract][Full Text] [Related]
19. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S
J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866
[TBL] [Abstract][Full Text] [Related]
20. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Casagrande F; Cocco E; Bellone S; Richter CE; Bellone M; Todeschini P; Siegel E; Varughese J; Arin-Silasi D; Azodi M; Rutherford TJ; Pecorelli S; Schwartz PE; Santin AD
Cancer; 2011 Dec; 117(24):5519-28. PubMed ID: 21692061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]